Lori McKenna Gorski
Direktor/Vorstandsmitglied bei Our Odyssey, Inc.
Aktive Positionen von Lori McKenna Gorski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Our Odyssey, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lori McKenna Gorski
Ehemalige bekannte Positionen von Lori McKenna Gorski
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYCLO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Public Communications Contact | 09.03.2011 | - |
RADIUS HEALTH, INC. | Public Communications Contact | - | - |
THERMO FISHER SCIENTIFIC | Public Communications Contact | - | - |
Ausbildung von Lori McKenna Gorski
Boston College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Public Communications Contact | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
THERMO FISHER SCIENTIFIC | Health Technology |
CYCLO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Our Odyssey, Inc. |
- Börse
- Insiders
- Lori McKenna Gorski
- Erfahrung